Advertisement

PharmacoEconomics & Outcomes News

, Volume 781, Issue 1, pp 25–26 | Cite as

News from ASCO

Clinical study

References

  1. Warsame RM, et al. How costs get discussed (or not) in routine oncology practice. 53rd Annual Meeting of the American Society of Clinical Oncology : abstr. 6512, 2 Jun 2017. Available from: URL: http://abstracts.asco.org/199/AbstView_199_190281.html.Google Scholar
  2. Aakhus E, et al. Implementing cost transparency in oncology: A qualitative study of barriers, facilitators, and patient preferences. 53rd Annual Meeting of the American Society of Clinical Oncology : abstr. 6597, 2 Jun 2017. Available from: URL: http://abstracts.asco.org/199/AbstView_199_190098.html.Google Scholar
  3. Goldstein DA, et al. A phamacoeconomic analysis of personalized dosing versus fixed dosing of pembrolizumab in first-line PD-L1 positive non-small cell lung cancer. 53rd Annual Meeting of the American Society of Clinical Oncology : abstr. 9013, 2 Jun 2017. Available from: URL: http://abstracts.asco.org/199/AbstView_199_182537.html.
  4. Alsaid N, et al. Cost effectiveness of carfilzomib (CAR), ixazomib (IXA), elotuzumab (ELO), or daratumumab (DAR) with lenalidomide and dexamethasone (LEN+DEX) vs LEN+DEX in relapsed/refractory multiple myeloma (R/R MM). 53rd Annual Meeting of the American Society of Clinical Oncology : abstr. 8030, 2 Jun 2017. Available from: URL: http://abstracts.asco.org/199/AbstView_199_190223.html.
  5. Carroll K, et al. Cost-effectiveness of nivolumab for treatment of platinum-resistant recurrent or metastatic squamous cell carcinoma of the head and neck. 53rd Annual Meeting of the American Society of Clinical Oncology : abstr. 6026, 2 Jun 2017. Available from: URL: http://abstracts.asco.org/199/AbstView_199_191262.html.
  6. The ASCO Post. ASCO 2017: Implementing Cost Transparency in Oncology. Internet Document : 8 Jun 2017. Available from: URL: http://www.ascopost.com/News/55725.

Copyright information

© Springer International Publishing AG  2017

Personalised recommendations